Platinum Investment Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Platinum Investment Management’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,639	Closed	-$87K	–	139
2022 Q3	$87K	Hold	3,639	–	–	﹤0.01%	112
2022 Q2	$72K	Hold	3,639	–	–	﹤0.01%	123
2022 Q1	$131K	Sell	3,639 -18,533	-84%	-$689K	﹤0.01%	119
2021 Q4	$993K	Hold	22,172	–	–	0.03%	111
2021 Q3	$1.58M	Hold	22,172	–	–	0.04%	108
2021 Q2	$2.93M	Buy	22,172 +9,297	+72%	+$1.16M	0.07%	81
2021 Q1	$1.73M	Hold	12,875	–	–	0.04%	95
2020 Q4	$942K	Buy	12,875 +2,196	+21%	+$161K	0.02%	113
2020 Q3	$812K	Buy	10,679 +293	+3%	+$19.7K	0.02%	111
2020 Q2	$831K	Hold	10,386	–	–	0.02%	111
2020 Q1	$424K	Hold	10,386	–	–	0.01%	111
2019 Q4	$843K	Hold	10,386	–	–	0.02%	91
2019 Q3	$719K	Hold	10,386	–	–	0.02%	90
2019 Q2	$1.27M	Buy	10,386 +676	+7%	+$100K	0.03%	77
2019 Q1	$1.67M	Buy	9,710 +2,598	+37%	+$388K	0.04%	72
2018 Q4	$1.02M	Hold	7,112	–	–	0.03%	72
2018 Q3	$2.27M	Hold	7,112	–	–	0.06%	49
2018 Q2	$2.53M	Buy	+7,112	New	+$2.2M	0.06%	48

Other funds holding ASLN

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Platinum Investment Management's ASLN Position: Q4 2022 in Review

Platinum Investment Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q4 2022, closing a stake of 3,639 shares — an estimated $87K sold.

Platinum Investment Management first reported a position in ASLN in Q2 2018 and held it in 18 quarters. The position peaked at $2.93M in Q2 2021. 24 funds tracked by Wall St. Rank hold ASLN as of Q4 2022.

Platinum Investment Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q4 2022 after selling out during the quarter.
Platinum Investment Management sold 3,639 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q4 2022, an estimated $87K.
Platinum Investment Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2018 and held it in 18 quarters.
Platinum Investment Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $2.93M in Q2 2021.
24 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q4 2022.

Based on Platinum Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.